Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
PubliRES - Publications, Research, Expertise and Skills Home
Italiano
English
Home
Profili
Unità di ricerca
Prodotti della ricerca
Dataset
Ricerca per competenza, nome o affiliazione
dasatinib-blinatumomab for ph positive acute lymphoblastic leukemia in adults
Simona Sica
Dipartimento di Scienze radiologiche ed ematologiche
Facoltà di Medicina e Chirurgia "A.Gemelli"
Ambito Disciplinare: MALATTIE DEL SANGUE, ONCOLOGIA E REUMATOLOGIA
Risultato della ricerca
:
Contributo in rivista
›
Articolo
24
Citazioni (Scopus)
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'dasatinib-blinatumomab for ph positive acute lymphoblastic leukemia in adults'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Pharmacology, Toxicology and Pharmaceutical Science
Dasatinib
100%
Acute Lymphoblastic Leukemia
100%
Blinatumomab
100%
Remission
40%
Disease Free Survival
40%
Group Trial
20%
Adverse Event
20%
Glucocorticoid
20%
Protein Tyrosine Kinase Inhibitor
20%
Overall Survival
20%
Philadelphia 1 Chromosome
20%
Minimal Residual Disease
20%
Cyclin Dependent Kinase Inhibitor 2A
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Blinatumomab
100%
Disease Free Survival
40%
Adverse Event
20%
Overall Survival
20%
Minimal Residual Disease
20%
Glucocorticoid
20%
Philadelphia 1 Chromosome
20%
Group Trial
20%
Cyclin Dependent Kinase Inhibitor 2A
20%
Tyrosine-Kinase Inhibitor
20%
Immunology and Microbiology
Blinatumomab
100%
Disease Free Survival
40%
Overall Survival
20%
Tyrosine
20%
Glucocorticoid
20%
Philadelphia 1 Chromosome
20%
Biochemistry, Genetics and Molecular Biology
Dasatinib
100%
IKZF1
40%
PAX5
20%